Andreas Rosenwald

New England Journal of Medicine · 2000–2022

A researcher in the Science corpus: 31 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Andreas Rosenwald trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Ash A. Alizadeh
2. Stuart Barber
3. Larry A. Wasserman

Who trusts Andreas Rosenwald overall

1. George W. Wright
2. Eric Bair
3. Jelle J. Goeman
4. Jiang Gui
5. S. Gaiffas
6. Christine Mayr
7. J. Dijksterhuis
8. Richard M. Simon
9. Robert Tibshirani
10. Liping Zhu

Papers from Andreas Rosenwald's perspective

Ordered by how strongly the researchers Andreas Rosenwald trusts endorse each paper. Same corpus, a different order for every researcher.

1. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. (Blood)
2. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. (Cell)
3. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
4. The RB and p53 pathways in cancer. (Cancer Cell)
5. A loss-of-function RNA interference screen for molecular targets in cancer (Nature)
6. c-Myc-regulated microRNAs modulate E2F1 expression (Nature)
7. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. (Cancer Cell)
8. Global variation in copy number in the human genome (Nature)
9. Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma (Science)
10. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. (Cancer Research)

Their papers

• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (2000) — 10,272 citations
• The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. (2003) — 970 citations
• MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts (2008) — 2,432 citations
• A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma (2003) — 1,084 citations
• Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia (2001) — 1,219 citations
• Identifying functional modules in protein–protein interaction networks: an integrated exact approach (2008) — 551 citations
• The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (2022) — 3,276 citations
• Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma (2018) — 1,854 citations
• Molecular Subtypes of Diffuse Large B-cell Lymphoma are Associated with Distinct Pathogenic Mechanisms and Outcomes (2018) — 1,686 citations
• Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. (2015) — 671 citations
• Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. (2014) — 705 citations
• Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics (2012) — 975 citations
• Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (2012) — 1,068 citations
• Chronic Active B Cell Receptor Signaling in Diffuse Large B Cell Lymphoma (2010) — 1,639 citations
• Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma (2010) — 1,222 citations
• Oncogenically active MYD88 mutations in human lymphoma (2010) — 1,509 citations
• The microenvironment in mature B-cell malignancies: a target for new treatment strategies. (2009) — 598 citations
• A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy (2009) — 660 citations
• Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways (2008) — 1,040 citations
• Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma (2008) — 886 citations